Introduction: Who Should Undergo Diagnostics

Combined immunodeficiency, often shortened to CID, is a group of rare genetic disorders where both main types of infection-fighting cells in the body—called T cells and B cells—are either too few in number or do not work properly. These cells are part of what is known as the adaptive immune system, which learns to recognize and fight off specific germs like bacteria, viruses, fungi, and parasites. When this system is weakened, even common infections that most people easily shake off can become serious or life-threatening.^[1]

Children with combined immunodeficiency often show signs of illness within the first two years of life. The most common warning signs include repeated infections that keep coming back, infections that do not respond well to treatment, or infections that are unusually severe. Some children may also experience problems with their immune system going into overdrive, causing inflammation or autoimmune conditions where the body mistakenly attacks its own tissues. This happens because the immune cells are present but do not function correctly, leading to what doctors call immune dysregulation.^[1]

Parents and caregivers should seek medical evaluation if their child has frequent or severe respiratory infections, chronic diarrhea that does not improve, skin rashes that persist, or fails to gain weight at a normal rate. These symptoms, especially when they occur repeatedly or do not improve with standard treatments, may suggest an underlying immune system problem. It is important to remember that some children with milder forms of CID may not show symptoms until later in childhood or even early adulthood, making it harder to detect the condition early.^[1]

Diagnostic Methods for Combined Immunodeficiency

Diagnosing combined immunodeficiency requires a combination of careful observation, detailed medical history, and specialized laboratory tests. Doctors begin by reviewing the child’s history of infections, including how often they occur, what types of germs cause them, and how the child responds to treatment. A physical examination is also important, as it can reveal specific findings associated with different forms of CID, such as skin rashes, poor growth, or signs of chronic inflammation.^[1]

The cornerstone of diagnosing CID is blood testing. A simple but essential test is the complete blood count, which measures the number of different types of blood cells, including white blood cells. Doctors pay close attention to the levels of lymphocytes, which are the white blood cells that include T cells and B cells. In combined immunodeficiency, the number of lymphocytes may be low, or they may be present but not functioning properly. The complete blood count can provide early clues that something is wrong with the immune system.^[4][10]

Beyond the basic blood count, doctors order more specialized tests to understand exactly which parts of the immune system are affected. These tests measure the specific numbers of T cells and B cells, as well as their ability to respond to challenges. For example, doctors may test whether B cells are making antibodies, which are proteins that target and destroy specific germs. They may also test how well T cells can activate and multiply when exposed to substances that should trigger an immune response. These functional tests help distinguish CID from other immune problems and identify the specific type of combined immunodeficiency a child has.^[1]

Another important part of the diagnostic process is genetic testing. Because combined immunodeficiency is caused by changes or mutations in specific genes, identifying the exact genetic variant can confirm the diagnosis and provide information about what to expect in terms of disease severity and progression. There are many different genetic variants that can cause CID, and each one affects the immune system in a slightly different way. Genetic testing can take weeks or months to complete, so doctors often start treatment based on clinical findings and blood tests while waiting for the genetic results.^[1]

Doctors may also use imaging tests or other procedures to check for complications of CID. For example, chest X-rays or CT scans can help identify lung infections or damage from repeated respiratory illnesses. In some cases, a biopsy of lymph nodes or other tissues may be needed to rule out other conditions or to understand the extent of immune system damage. However, these tests are not always necessary and depend on the individual child’s symptoms and medical history.^[4]

It is important to note that the diagnosis of combined immunodeficiency is not always straightforward. Some children with milder forms of CID may have normal or near-normal lymphocyte counts, making it harder to detect the problem through routine blood tests. In these cases, functional tests that measure how well the immune cells work become even more important. Doctors may also repeat tests over time to look for patterns or trends, especially if the child’s condition is borderline or unclear.^[1]

Diagnostics for Clinical Trial Qualification

When families consider enrolling their child in a clinical trial to test new treatments for combined immunodeficiency, additional diagnostic tests are often required. Clinical trials are research studies designed to find out whether a new treatment is safe and effective, and they have strict criteria for who can participate. These criteria, called inclusion and exclusion criteria, help ensure that the trial results are reliable and that participants are appropriate candidates for the experimental treatment being tested.

For combined immunodeficiency trials, doctors typically require a confirmed diagnosis through blood tests showing low or abnormal T cell and B cell function. Genetic testing is often necessary to identify the specific gene mutation causing the condition, as some trials are designed for specific genetic types of CID. For example, a trial testing a new gene therapy might only accept children with a particular genetic variant that the therapy is designed to correct.^[1]

Clinical trials may also require baseline measurements of the child’s immune system before starting the experimental treatment. This includes detailed counts of different types of lymphocytes, measurements of antibody levels, and tests of how well the immune cells respond to stimulation. These baseline measurements help researchers track whether the treatment is having an effect and whether the child’s immune system is improving over time. Without accurate baseline data, it would be difficult to determine if the treatment is working.

In addition to immune system tests, clinical trials often require general health assessments to make sure the child is healthy enough to participate. This may include tests of liver and kidney function, heart function, and overall nutritional status. Doctors may also check for active infections that need to be treated before starting the trial, as some experimental treatments could make infections worse if they are not controlled first.

Some trials may have age restrictions or require that the child be at a certain stage of the disease. For example, a trial might only accept children who have not yet received a bone marrow transplant, or it might focus on children with very severe forms of CID who have already tried other treatments without success. These requirements are designed to create a consistent group of participants so that researchers can accurately measure the treatment’s effects.